Bioventus (BVS) Liabilities and Shareholders Equity (2020 - 2026)
Bioventus' Liabilities and Shareholders Equity came in at $673.35 million for Q2 2026, down 4.7% from $706.79 million a year earlier but up 3.5% from the prior quarter.
Powered by 
Analysis
Bioventus (BVS) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Bioventus' Liabilities and Shareholders Equity was $683.56 million, down 6.1% from FY2024.
- Liabilities and Shareholders Equity has declined in each of the last three years, though with a five-year compound annual growth rate of 6.7% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $727.96 million in FY2024 (-10.2%), $810.91 million in FY2023 (-40.9%), $1.37 billion in FY2022 (+12.0%) and $1.23 billion in FY2021 (+147.9%).
- The five-year range for quarterly Liabilities and Shareholders Equity is $650.54 million (Q1 2026) to $1.4 billion (Q3 2022).
- Year-over-year, Liabilities and Shareholders Equity has declined for 14 consecutive quarters, with an average decline of 8.1% over the last eight quarters.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2021 (growth of 147.9%), and the weakest in Q3 2023 (a decline of 42.0%).
- Business Quant data shows BVS's Liabilities and Shareholders Equity at $650.54 million (Q1 2026), $683.56 million (Q4 2025) and $701.59 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 113.17 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 109.22 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 92.37 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 20.88 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 47.93 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 45.22 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 13.87 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 50.73 Bn |
| 10 | Bioventus | 1.14 Bn | 1.04 Bn | 105.67 Mn | 673.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 673.35 Mn |
| Mar 28, 2026 | 650.54 Mn |
| Dec 31, 2025 | 683.56 Mn |
| Sep 27, 2025 | 701.59 Mn |
| Jun 28, 2025 | 706.79 Mn |
| Mar 29, 2025 | 691.41 Mn |
| Dec 31, 2024 | 727.96 Mn |
| Sep 28, 2024 | 769.49 Mn |
| Jun 29, 2024 | 792.17 Mn |
| Mar 30, 2024 | 794.24 Mn |
| Dec 31, 2023 | 810.91 Mn |
| Sep 30, 2023 | 811.10 Mn |
| Jul 1, 2023 | 836.96 Mn |
| Apr 1, 2023 | 887.40 Mn |
| Dec 31, 2022 | 1.37 Bn |
| Oct 1, 2022 | 1.40 Bn |
| Jul 2, 2022 | 1.21 Bn |
| Apr 2, 2022 | 1.20 Bn |
| Dec 31, 2021 | 1.23 Bn |
| Oct 2, 2021 | 654.79 Mn |
API Access
Bioventus Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();